ANGLE plc

ANGLE plc

ANGLE plc

Overview
Date Founded

2003

Headquarters

The Surrey Research Park,3 Frederick Sanger Road,Guildford, Surrey GU2 7YD

Type of Company

Public

Employees (Worldwide)

31

Industries

Management Consulting
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Holding Companies
Commercial Scientific Research
Advertising & Marketing

Company Description

ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.

Executives & Employees

Chief Financial Officer, Secretary & Executive Director

Chief Technology Officer

Chief Scientific Officer

Vice President, Chief Executive Officer Angle BioSciences, Inc

Director of Manufacturing & Regulatory Affairs

Director-Business Development

Vice President-NA

US Vice President Sales

Clinical Studies Director

Board of Directors

Former Chief Executive Officer at Comino Group Plc

President, Chief Executive Officer & Executive Director at MDxHealth SA

Paths to ANGLE plc
Potential Connections via
Relationship Science
You
ANGLE plc
Owners & Shareholders
Details Hidden

MDB-IM is a risk-averse investment manager who follows a growth-oriented and flexible investment approach, focused on long-term capital appreciation. Their investment process consists of stock picking rather than focusing on specific sectors or market caps. Stock research is performed in house and often includes a company visit. Under unfavorable market conditions, the firm's portfolios are weighted in money-market instruments.The firm individually tailors portfolios to meet their clients' particular requirements. They avoid investment decisions based on rumored mergers and acquisitions, and generally dispose of underperforming assets. They have specific expertise in small-cap investing and manage diversified portfolios invested primarily in companies quoted on the AIM market.

Details Hidden

MDB-IM is a risk-averse investment manager who follows a growth-oriented and flexible investment approach, focused on long-term capital appreciation. Their investment process consists of stock picking rather than focusing on specific sectors or market caps. Stock research is performed in house and often includes a company visit. Under unfavorable market conditions, the firm's portfolios are weighted in money-market instruments.The firm individually tailors portfolios to meet their clients' particular requirements. They avoid investment decisions based on rumored mergers and acquisitions, and generally dispose of underperforming assets. They have specific expertise in small-cap investing and manage diversified portfolios invested primarily in companies quoted on the AIM market.

Recent Transactions
Details Hidden

ANGLE plc purchases Axela, Inc. /Certain Assets from Axela, Inc.

Details Hidden

ANGLE plc issued Ordinary Shares

Details Hidden

SVF Holdco (UK) Ltd. purchases Geomerics Ltd. from ANGLE plc

Transaction Advisors
Broker

Advised onANGLE plc issued Ordinary Shares

Legal Advisor

Advised onANGLE plc issued Ordinary Shares

Auditor

Advised onANGLE plc issued Ordinary Shares

Advisors & Consultants
Scientific Advisor

Chief Scientific Officer at Phoremost Ltd.

Scientific Advisor

Assistant Attending Physician at Memorial Sloan-Kettering Cancer Center

Scientific Advisor

Vice President, Sequencing at New York Genome Center, Inc.

Key Stats and Financials As of 2018
Market Capitalization
$66.2M
Total Enterprise Value
$37.1M
Earnings Per Share
$-0.08
Revenue
$628K
Net Profit
$-7.56M
EBITDA
$-9.46M
EBITDAMargin
-1,506.21%
Total Debt
$0
Total Equity
$15.9M
Enterprise Value Sales
59.02x
TEVNet Income
-4.91x
Debt TEV
0x
Five Year Compounded Annual Growth Rate Of Revenue
-8.31%
Three Year Compounded Annual Growth Rate Of Revenue
-14.65%